Psychosis in Parkinson's Disease

被引：1

作者：

Remz, Matthew ^{[1
]}

Salinas, Meagen ^{[1
]}

机构：

[1] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, 5323 Harry Hines Blvd, Dallas, TX 75390 USA

来源：

PSYCHIATRIC ANNALS | 2020年 / 50卷 / 03期

关键词：

DRUG-INDUCED PSYCHOSIS; VISUAL HALLUCINATIONS; RISPERIDONE TREATMENT; CLOZAPINE; SYMPTOMS; ZIPRASIDONE; OLANZAPINE; PHENOMENOLOGY; ARIPIPRAZOLE; RIVASTIGMINE;

D O I：

10.3928/00485713-20200210-02

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

Clinically defined by consensus in 2007, Parkinson's disease psychosis (PDP) encompasses psychiatric symptoms of illusions, hallucinations, and delusions associated with Parkinson's disease. Since that time, an increase in research has yielded new insights into clinical features of PDP, how these symptoms evolve over time, and novel therapeutic targets. This article reviews the literature surrounding PDP, highlighting the spectrum of clinical manifestations, the pathophysiology, and treatment options. The article concludes with a treatment strategy incorporating the reviewed evidence.

引用

页码：112 / 119

页数：8

共 50 条

[41] CBT for psychosis in Parkinson's disease: A framework for how and why [J].

Foley, Jennifer A. ;

Bell, Vaughan .

SCHIZOPHRENIA RESEARCH, 2025, 280 :69-75

[42] Treating Hallucinations and Delusions Associated With Parkinson's Disease Psychosis [J].

Panchal, Shyam C. ;

Ondo, William G. .

CURRENT PSYCHIATRY REPORTS, 2018, 20 (01)

[43] The psychosis spectrum in Parkinson disease [J].

Ffytche, Dominic H. ;

Creese, Byron ;

Politis, Marios ;

Chaudhuri, K. Ray ;

Weintraub, Daniel ;

Ballard, Clive ;

Aarsland, Dag .

NATURE REVIEWS NEUROLOGY, 2017, 13 (02) :81-95

[44] Parkinson disease psychosis: Update [J].

Friedman, J. H. .

BEHAVIOURAL NEUROLOGY, 2013, 27 (04) :469-477

[45] Brainstem Pathologies Correlate With Depression and Psychosis in Parkinson's Disease [J].

Fischer, Nicole Mercado ;

Hinkle, Jared T. ;

Perepezko, Kate ;

Bakker, Catherine C. ;

Morris, Meaghan ;

Broen, Martinus P. G. ;

Butala, Ankur ;

Dawson, Ted M. ;

Leentjens, Albert F. G. ;

Mari, Zoltan ;

Marvel, Cherie L. ;

Mills, Kelly A. ;

Rosenthal, Liana S. ;

Shepard, Melissa D. ;

Pantelyat, Alexander ;

Bakker, Arnold ;

Pletnikova, Olga ;

Troncoso, Juan C. ;

Wang, Jiangxia ;

Pontone, Gregory M. .

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2021, 29 (09) :958-968

[46] Incidence, Prevalence, and Mortality of Psychosis Associated with Parkinson's Disease (1991-2010) [J].

Stang, Cole D. ;

Mullan, Aidan F. ;

Camerucci, Emanuele ;

Hajeb, Mania ;

Turcano, Pierpaolo ;

Martin, Peter ;

Mielke, Michelle M. ;

Josephs, Keith A. ;

Splett, Matthew ;

Abler, Victor ;

Boeve, Bradley F. ;

Bower, James H. ;

Savica, Rodolfo .

JOURNAL OF PARKINSONS DISEASE, 2022, 12 (04) :1319-1327

[47] Treating dopamimetic psychosis in Parkinson's disease:: Structured review and meta-analysis [J].

Frieling, Helge ;

Hillemacher, Thomas ;

Ziegenbein, Marc ;

Neundoerfer, Bernhard ;

Bleich, Stefan .

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 (03) :165-171

[48] Treatment of Psychosis in Parkinson’s DiseaseSafety Considerations [J].

Hubert H. Fernandez ;

Martha E. Trieschmann ;

Joseph H. Friedman .

Drug Safety, 2003, 26 :643-659

[49] Pimavanserin for the treatment of Parkinson's disease psychosis: number needed to treat, number needed to harm, and likelihood to be helped or harmed [J].

Citrome, Leslie ;

Norton, James C. ;

Chi-Burris, Kathy ;

Demos, George .

CNS SPECTRUMS, 2018, 23 (03) :228-238

[50] Pimavanserin for the treatment of Parkinson's disease psychosis [J].

Chendo, Ines ;

Ferreira, Joaquim J. .

EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (15) :2115-2124

← 1 2 3 4 5 →